Walter M. Stadler to Compassionate Use Trials
This is a "connection" page, showing publications Walter M. Stadler has written about Compassionate Use Trials.
Connection Strength
0.090
-
Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America. Cancer. 2010 Mar 01; 116(5):1272-80.
Score: 0.090
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.